Aytu Biopharma, Inc. (AYTU)
2.14
+0.02
(+0.94%)
USD |
NASDAQ |
Sep 21, 16:00
2.14
0.00 (0.00%)
After-Hours: 20:00
Aytu Biopharma Debt to Equity Ratio : 0.6527 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.6527 |
| December 31, 2025 | 1.556 |
| September 30, 2025 | 1.226 |
| June 30, 2025 | 1.209 |
| March 31, 2025 | 0.6454 |
| December 31, 2024 | 0.5571 |
| September 30, 2024 | 0.6097 |
| June 30, 2024 | 0.5924 |
| March 31, 2024 | 1.028 |
| December 31, 2023 | 0.9626 |
| September 30, 2023 | 1.033 |
| June 30, 2023 | 0.7731 |
| March 31, 2023 | 1.020 |
| December 31, 2022 | 0.8657 |
| September 30, 2022 | 0.8273 |
| June 30, 2022 | 0.8203 |
| March 31, 2022 | 0.4645 |
| December 31, 2021 | 0.3364 |
| September 30, 2021 | 0.3025 |
| June 30, 2021 | 0.2748 |
| March 31, 2021 | 0.2627 |
| December 31, 2020 | 0.1086 |
| September 30, 2020 | 0.1547 |
| June 30, 2020 | 0.1633 |
| March 31, 2020 | 0.055 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.0171 |
| September 30, 2019 | 0.1353 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.3202 |
| December 31, 2018 | 0.2531 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.0006 |
| December 31, 2015 | 0.3225 |
| September 30, 2015 | 0.3599 |
| March 31, 2015 | 14.51 |
| February 28, 2015 | -0.69 |
| November 30, 2014 | -0.7256 |
| August 31, 2014 | -0.6889 |
| May 31, 2014 | -0.7917 |
| February 28, 2014 | -0.7645 |
| November 30, 2013 | -0.832 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 111.69M |
| Total Liabilities (Quarterly) | 76.55M |
| Shareholders Equity (Quarterly) | 35.14M |
| Current Ratio | 1.123 |
| Net Debt Paydown Yield | -3.96% |